ZALICUS PHARMACEUTICALS
Zalicus Pharmaceuticals operates as a biopharmaceutical company which develops chronic pain drugs.
ZALICUS PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2009-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.zalicus.com
Total Employee:
11+
Status:
Active
Contact:
+1-604-909-2530
Similar Organizations
Aerogen, Inc.
Aerogen, Inc. operates as a specialty pharmaceutical company that develops, manufactures, and commercializes pulmonary.
AlcaSynn Pharmaceuticals GmbH
Drug development company focusing on small molecules of the morphinan group. In 2006 AlcaSynn was acquired by Sanochemia Pharmazeutika
Altum Pharmaceuticals
Altum Pharmaceuticals operates as a biopharmaceutical company.
Avenzoar Pharmaceuticals
Avenzoar Pharmaceuticals is a pharmaceutical company developing cancer drugs.
Maxim Pharmaceuticals
Maxim Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative cancer therapeutics.
P2D Bioscience
This company is a specialty pharmaceutical company focused on developing innovative drugs.
Patrin Pharma
Patrin Pharma is a pharmaceutical company that develops a portfolio of niche generic products.
Rivus Pharmaceuticals
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.
Wex Pharmacetuicals
WEX Pharmaceuticals Inc. is a biopharmaceutical company that developing a late-stage non-opioid analgesic.
Official Site Inspections
http://www.zalicus.com
- Host name: ec2-13-56-33-8.us-west-1.compute.amazonaws.com
- IP address: 13.56.33.8
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Zalicus Pharmaceuticals"
Zalicus - Crunchbase Company Profile & Funding
Organization. Zalicus . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Zalicus discovers and develops novel-target pain …See details»
Zalicus 2025 Company Profile: Valuation, Investors, Acquisition
Zalicus General Information Description. Developer of treatments for pain and inflammation drugs based in Cambridge, Massachusetts. The company applies ion-channel modulation expertise …See details»
Zalicus Pharmaceuticals - Crunchbase Company Profile & Funding
View contacts for Zalicus Pharmaceuticals to access new leads and connect with decision-makers.See details»
Zalicus - Company Profile - Tracxn
Feb 25, 2025 Zalicus Inc., formerly CombinatoRx, Incorporated, is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain and inflammation.See details»
Zalicus Information - RocketReach
Zalicus discovers and develops innovative therapeutics for patients in need. We believe that our novel product candidates, productive drug discovery platforms, drug development expertise, …See details»
Zalicus Pharmaceuticals Ltd - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Zalicus Pharmaceuticals Ltd of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
Zalicus Company Profile | Management and Employees List
Zalicus Profile and History. About Zalicus Zalicus Inc. (NASDAQ: ZLCS) is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and …See details»
Zalicus Pharmaceuticals Ltd Company Profile, Financial and …
Zalicus Pharmaceuticals Ltd. operates as a biopharmaceutical company which develops chronic pain drugs. Zalicus Pharmaceuticals Ltd. was formerly known as Neuromed Pharmaceuticals …See details»
Zalicus Pharmaceuticals - Ownership and Business Overview
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015.The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for …See details»
Zalicus Pharmaceuticals acquired by Taro Pharmaceuticals
Oct 14, 2015 Acquired Organization: Zalicus Pharmaceuticals Zalicus Pharmaceuticals operates as a biopharmaceutical company which develops chronic pain drugs. Acquiring Organization: …See details»
Organization | Zalicus - Purdue University
Organization Overview. First Clinical Trial. 2009 NCT00747214. First Marketed Drug. None First NDA Approval. None Last Known Activity. 2012 Timeline < Back; View all... NOW. Now; Active …See details»
CombinatoRx Changes Company Name to Zalicus Inc.
Sep 9, 2010 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that it has changed its name to Zalicus Inc.The company will begin …See details»
ZALICUS INC. Company Profile | Cambridge, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ZALICUS INC. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Zalicus - Ownership and Business Overview - Mergr
Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and inflammation.See details»
Zalicus Pharmaceuticals - PitchBook
Zalicus Pharmaceuticals General Information Description. Developer of chronic pain drugs. The company's pain management drugs target neuronal calcium channels to treat neurological …See details»
Zalicus, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Zalicus, Inc. with its drug pipeline, therapeutic area, technology platform, 21 clinical trials, 15 news, and 40 literature, Disease Domain:Endocrinology and ...See details»
Zalicus | IT History Society
Zalicus discovers and develops novel-target pain therapies, including calcium channel modulator for chronic and acute inflammatory pain.Zalicus Inc., formerly CombinatoRx, Incorporated, is a …See details»
Home - falicus.com
Evolviamo Aziende e Persone Le Aziende e le Organizzazioni hanno 4 temi di forte crisi: •Incrementare Benessere e Sicurezza •Migliorare efficienza-OEE impianti •Attrarre e …See details»
Company Zalicus Inc Nasdaq - MarketScreener.com
Zalicus Inc: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: | NasdaqSee details»
U.S. arm of Sun Pharma's Taro buys Zalicus Pharmaceuticals of …
Oct 14, 2015 The acquisition of Canada's Zalicus Pharmaceuticals by a U.S. subsidiary of India's largest drugmaker, Sun Pharmaceuticals, is being seen as a move to strengthen its …See details»